Skip to content
ppharmaranks
Menu
Class IOngoing

Docetaxel Injection recall

FDA recall D-0554-2024 · initiated May 28, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jun 19, 2024How we research

Sagent Pharmaceuticals recalled Docetaxel Injection in May 2024 — an FDA Class I recall (D-0554-2024) because Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: F1030001, Exp. Date 12/31/2024

Quantity recalled: 2806 vials

Details

Product
Docetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08
Recalling company
Sagent
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide within the USA.
Initiated
May 28, 2024
FDA report date
Jun 19, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Docetaxel Injection recalled?
Sagent Pharmaceuticals recalled Docetaxel Injection in May 2024 — an FDA Class I recall (D-0554-2024) because Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product. Most serious — a reasonable probability that use will cause serious harm or death.
Why was Docetaxel Injection recalled?
Per the FDA enforcement record, the reason for recall D-0554-2024 was: Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Is a recalled Docetaxel Injection dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Docetaxel Injection are affected?
Distributed: Nationwide within the USA.. The recall covers these lots — Lot #: F1030001, Exp. Date 12/31/2024. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0554-2024.

Source: openFDA Drug Enforcement record D-0554-2024

← All drug recalls